Limitations of characterization of hepatic hemangiomas using a sonographic contrast agent (Levovist) and power Doppler ultrasonography.

Power Doppler ultrasonography using a sonographic contrast agent (Levovist) was evaluated in 20 patients with hepatic hemangiomas with a 2‐4 MHz convex transducer according to a standardized examination protocol (pulse repetition frequency, 1000 Hz; medium wall filter; power Doppler gain, 50 to 85%). Enhancement patterns were assessed and were compared with those on dynamic magnetic resonance imaging (n = 11) or computed tomography (n = 9). The most common enhancement pattern was dotlike or linear enhancement located predominantly at the periphery of the tumor (15 cases, 75%). Diffuse homogeneous enhancement was seen in one case (5%). No definite contrast enhancement was evident in four cases (20%). The enhanced area on ultrasonograms was smaller than that on dynamic MR images or CT scans in 18 cases (90%). A transient centripetal fill‐in pattern was identified in six cases (30%). Persistent enhancement until 300 s was not seen in any case. Therefore, specific diagnosis of hemangioma with power Doppler ultrasonography and contrast agent may not be possible.

[1]  E. Grant,et al.  Clinical experience with sonographic contrast agents. , 1997, Seminars in ultrasound, CT, and MR.

[2]  H P Weskott.  Amplitude Doppler US: slow blood flow detection tested with a flow phantom. , 1997, Radiology.

[3]  N. Hosten,et al.  Contrast‐enhanced power Doppler sonography: Improved detection of characteristic flow patterns in focal liver lesions , 1999, Journal of clinical ultrasound : JCU.

[4]  F Lodi Rizzini,et al.  [A high-resolution computed tomographic study of the pulmonary interstitium in systemic autoimmune diseases]. , 1994, La Radiologia medica.

[5]  R. Schlief,et al.  Blood‐Pool Enhancement with SH U 508 A: Results of Phase II Clinical Trials , 1991, Investigative radiology.

[6]  S. Sironi,et al.  Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization. , 1994, La Radiologia medica.

[7]  E. G. Hahn,et al.  Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist® , 1996, Journal of clinical ultrasound : JCU.

[8]  D. Merton,et al.  Color amplitude imaging: preliminary results using vascular sonographic contrast agents. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[9]  B. Barbaro,et al.  Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience. , 1994, La Radiologia medica.

[10]  Color Doppler Sonography of Hepatic Tumors with a Galactose-Based Contrast Agent: Correlation with Angiographic Findings , 1995 .

[11]  F Forsberg,et al.  Artifacts in ultrasonic contrast agent studies. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[12]  C. McArdle,et al.  Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: A preliminary report , 1994, The British journal of surgery.

[13]  C. Sehgal,et al.  Power, spectral, and color flow Doppler enhancement by a new ultrasonographic contrast agent. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[14]  M. Lafortune,et al.  Power Doppler US in synovitis: reality or artifact? , 1996, Radiology.

[15]  B. Choi,et al.  Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results. , 1998, Radiology.

[16]  B. I. Choi,et al.  Signal from hepatic hemangiomas on power Doppler US: real or artefactual? , 1999, Ultrasound in medicine & biology.

[17]  S Tano,et al.  Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study. , 1997, Clinical radiology.

[18]  W Siegenthaler,et al.  Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique. , 1974, Microvascular research.

[19]  A. Duerinckx,et al.  Ability of a phase shift US contrast agent to improve imaging of the main renal arteries. , 1997, Radiology.

[20]  B. Choi,et al.  Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. , 1996, Radiology.